On November 14, 2019 Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, reported that it will participate in the Stifel Healthcare Conference on November 19 in New York City and Jefferies London Healthcare Conference on November 21 (Press release, Kindred Healthcare, NOV 14, 2019, View Source [SID1234551324]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Richard Chin, Chief Executive Officer, will present and be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, including the launch of KindredBio’s first product, study results from key therapeutic programs in development, and upcoming milestones.

Conference Details:

Stifel Healthcare Conference

Date: Tuesday, November 19, 2019

Presentation time: 10:20-10:50a.m. ET in Kennedy

Location: Lotte New York Palace Hotel

Webcast URL: Click here

Jefferies London Healthcare Conference

Date: Thursday, November 21, 2019

Location: Waldorf Hilton, London

An archived version of the above webcast will be available for 30 days on the KindredBio website.